Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
24.67
+0.84 (3.52%)
At close: Aug 21, 2026, 4:00 PM EDT
24.18
-0.49 (-1.99%)
After-hours: Aug 21, 2026, 6:29 PM EDT

Pacira BioSciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
14.647.03-99.5641.9615.9141.98
Depreciation & Amortization
85.6491.0278.7975.578128.55
Other Amortization
2.4133.223.757.2125.91
Asset Writedown & Restructuring Costs
25.8725.87163.24-36.63-
Loss (Gain) From Sale of Investments
-2.416.07-7.42-4.5810-
Stock-Based Compensation
55.9757.551.1747.948.0942.25
Other Operating Activities
5.17-0.2411.0531.25-37.1412.55
Change in Accounts Receivable
-21.77-10.74-7.75-7.16-2.08-10.43
Change in Inventory
3.76-27.57-20.93-8.292.49-4.47
Change in Accounts Payable
-12.69-5.63.080.926.27-10.26
Change in Other Net Operating Assets
31.095.6414.5-26.67-23.11-0.35
Operating Cash Flow
187.66151.99189.39154.65145.27125.72
Operating Cash Flow Growth
39.50%-19.74%22.46%6.45%15.56%63.20%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-8.15-15.33-10.64-15.16-30.08-45.87
Cash Acquisitions
-0.34-16.7---32-424.04
Investment in Securities
102.63131.52-72.6492.7-163.11449.12
Investing Cash Flow
94.1599.48-83.2877.54-225.19-20.79

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-101287.5149.55-363.75
Long-Term Debt Repaid
--317.8-210.89-330.31-427.69-
Net Debt Issued (Repaid)
-220.24-216.876.62-180.76-427.69363.75
Issuance of Common Stock
3.923.32.34.7527.3426.66
Repurchase of Common Stock
-157.67-153.95-25.49-0.11--
Other Financing Activities
-2.19-2.19-36.06-6.91-1.18-9.71
Financing Cash Flow
-376.18-369.6317.36-183.03-401.53380.69

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.24-0.08----
Net Cash Flow
-94.61-118.23123.4849.16-481.44485.62

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
179.52136.66178.75139.49115.279.85
Free Cash Flow Growth
53.34%-23.55%28.15%21.09%44.27%103.54%
Free Cash Flow Margin
24.06%18.81%25.50%20.67%17.28%14.74%
Free Cash Flow Per Share
4.233.033.872.682.481.75
Levered Free Cash Flow
92.84108.56163.38107.159249.79
Unlevered Free Cash Flow
100.11116.47170.52116.09109.7843.72

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
13.7215.2415.4227.6433.37
Cash Income Tax Paid
1.699.01114.47.43.22
Change in Working Capital
0.38-38.27-11.1-41.2-16.43-25.51
SEC Filings: 10-K · 10-Q